Skip to main content
Top
Published in: Reactions Weekly 1/2023

01-12-2023 | Neutropenia | Case report

Multiple drugs

Febrile neutropenia and lack of efficacy: case report

Published in: Reactions Weekly | Issue 1/2023

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literature
go back to reference Nara K, et al. Low pretherapy skeletal muscle mass index is associated with an increased risk of febrile neutropenia in patients with esophageal cancer receiving docetaxel + cisplatin + 5-fluorouracil (DCF) therapy. Supportive Care in Cancer 31: 150, No. 2, Feb 2023. Available from: URL: https://www.springer.com/journal/520 Nara K, et al. Low pretherapy skeletal muscle mass index is associated with an increased risk of febrile neutropenia in patients with esophageal cancer receiving docetaxel + cisplatin + 5-fluorouracil (DCF) therapy. Supportive Care in Cancer 31: 150, No. 2, Feb 2023. Available from: URL: https://​www.​springer.​com/​journal/​520
Metadata
Title
Multiple drugs
Febrile neutropenia and lack of efficacy: case report
Publication date
01-12-2023
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2023
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-51585-x

Other articles of this Issue 1/2023

Reactions Weekly 1/2023 Go to the issue

Case report

Cyclophosphamide

Case report

Clopidogrel

Case report

Multiple drugs

Case report

COVID-19 vaccine